The American Academy of Pain Medicine      Annual Meeting Home Page     
23rd Annual Meeting
February 7-10, 2007
New Orleans, LA
Annual Meeting Highlights
Supported by an educational grant from Merck & Co., Inc.



© 2006 American Academy of Pain Medicine
 


Saturday, February 10, 2007: 11:00 AM-12:00 PM
A Decade of the FDAMA: Understanding the Compounding Pharmacy and Optimizing Its Use
This session will provide an overview of an important but often misunderstood resource for physicians seeking to customize optimal drug therapies for their patients. The compounding of pharmaceuticals under the Food and Drug Administration (FDA) Modernization Act of 1997 does not fall under the same regulatory process administered by the FDA. Physicians considering compounded pharmaceuticals must have a firm understanding of a number of critical issues related to their use, including regulatory issues, the importance of selecting an appropriate compounding pharmacy with rigorous preparation standards, and the need for educating the patient. This symposium will review the legislation regulating compounding pharmacies, the types and amounts of medications they can formulate, and characteristics that distinguish them from drug manufacturers. The session will also focus on a clinician’s responsibilities when using a compounded drug outside the bounds of the approved product insert.
Submitter:Donna Bloodworth, MD
11:00 AM Introductory Remarks
11:05 AM Compounding Pharmacy: Its History, Its Current Applications in the US, and How Compounded Pharmaceuticals Differ from FDA Approved Medications
Loyd V. Allen, PhD, RPh
11:30 AM The FDA Process of Drug Approval and Key Differences Between Compounding Medications
Bradley Galer, M.D.
11:55 AM Question and Answer Session

See more of Recorded Sessions

See more of Annual Meeting